Urolithin B/Ellagitannin 1139-83-9/Mitoxantrone 65271-80-9/Lomustine 13010-47-4/Everolimus 159351 -69-6 /99% Gemcitabine Hydrochloride CAS 122111-03-9

China Urolithin B/Ellagitannin 1139-83-9/Mitoxantrone 65271-80-9/Lomustine 13010-47-4/Everolimus 159351-69-6 /99% Gemcitabine Hydrochloride CAS 122111-03-9, Find details about China Urolithin B/Ellagitannin, 1139-83-9 from Urolithin B/Ellagitannin 1139-83-9/Mitoxantrone 65271-80-9/Lomustine 13010-47-4/Everolimus 159351-69-6 /99% Gemcitabine Hydrochloride CAS 122111-03-9

Basic Info.

Model NO.

Gemcitabine Hydrochloride

C9h12clf2n3o4

299.66

CAS

122111-03-9

Appearance

White Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Model NO.

Gemcitabine Hydrochloride

C9h12clf2n3o4

299.66

CAS

122111-03-9

Appearance

White Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Product Desciption

Urolithin B/Ellagitannin 1139-83-9/Mitoxantrone 65271-80-9/Lomustine 13010-47-4/Everolimus 159351-69-6 /99% Gemcitabine Hydrochloride CAS 122111-03-9

Introduction

Product Name: Gemcitabine hydrochloride
Synonyms: 2',2'-difluorodeoxycytidinemonohydrochloride;2'-deoxy-2',2'-difluorocytidinemonohydrochloride;2'-deoxy-2',2'-difluoro-cytidinmonohydrochloride;gemzar;ly188011;ly188011hydrochloride;2',2'-DIFLUORO-2'-DEOXYCYTIDINE;2'-DEOXY-2',2'-DIFLUOROCYTIDINE
CAS: 122111-03-9
MF: C9H12ClF2N3O4
MW: 299.66
EINECS: 601-823-3

Melting point: >250°C dec.
Boiling point: 329.1±15.0 °C
Density: 1.137±0.06 g/cm3
Storage temp.: Desiccate at +4°C
Appearance: White Powder

Function

Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. It is researched and developed by the Eli Lilly and Company and approved to be listed in South Africa, Sweden, the Netherlands, Australia and other countries in 1995. The United States Food and Drug Administration ( referred FDA) approved it as the first-line therapy for the clinical treatment of non-small cell lung cancer and pancreatic cancer.

Application

Suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
specification

item	standard	result
appearance	white or almost white crystalline powder	off-white crystalline powder
identification	IR:the IR spectrum of the sample is consistent with that of the reference spectrum.	conforms
	HPLC:the relative retention time of major peak of the sample solution corresponds to that of the standard solution,as obtained in the assay.	conforms
	Chloride:It meets the requirements of the tests for chloride	conforms
solubility	soluble in water,slightly soluble in methanol,practically insoluble in ethanol,shloroform or acetone.	conforms
specifie rotation	+43°~+50°	+47°
acidity	2.0-3.0	2.6
loss on drying	≤1.0%	0.14%
residue on ignition	≤0.1%	0.02%
heavy metals	≤10ppm	conforms
related substances	cytosine≤0.1%	0.0049%
	gemcitabineα-anomer≤0.1%	0.0020%
	any single unidentified impurity≤0.1%	0.012%
	total impurities≤0.2%	0.023%
residue solvents	methanol≤0.3%	0.0018%
residue solvents	ethanol≤0.5%	not detected
bacterial endotoxins	<0.05EU/mg (Calculate as Gemcitabine)	<0.03EU/mg